New Study Fuels Debate on Semaglutide's Mental Health Risks

Researchers find potential link between popular weight loss drug and suicidal thoughts, but experts urge caution in interpreting results.

Semaglutide, used in Ozempic and Wegovy, is linked to higher reports of suicidal thoughts compared to other medications.
The study analyzed data from over 140 countries, highlighting a 45% increased risk of suicidal ideation for semaglutide users.
Conflicting evidence exists, with some studies suggesting no link or even a lower risk of suicidal thoughts with semaglutide.
Experts criticize the study's methods, noting potential biases and the difficulty of establishing causation.
Calls for further research emphasize the need to understand the drug's impact on mental health, especially for those with a history of depression.